With reference to the captioned subject we would like to state as under:
1. The Company has made all the necessary disclosures pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 from time to time and has not withheld any material information/ announcement that in our opinion would have a bearing on the price / volume behavior in the scrip.
2. As on date there are no pending information/ announcement (including impending announcement) which in our opinion may have a bearing on the price / volume behavior in the scrip.
You are requested to take the same on records.
Panacea Biotec: Clarification On Movement In Price
April 29, 2021
Download PDF
Panacea Biotec
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month